Page 3 - Davido Watson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Davido watson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Davido Watson Today - Breaking & Trending Today

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) General Counsel Sells $271,960.00 in Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) General Counsel Sells $271,960.00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Davido Watson , Robertw Baird , Apellis Pharmaceuticals , Quarter For Apellis Pharmaceuticals , Wells Fargo Company , Apellis Pharmaceuticals Inc , Jennison Associates , Apellis Pharmaceuticals Price Performance , American Investors Co , Lisanti Capital Growth , Apellis Pharmaceuticals Company Profile , Needham Company , News Ratings For Apellis Pharmaceuticals Daily , Institutional Investors Weigh In On Apellis Pharmaceuticals , Envestnet Asset Management Inc , Goldman Sachs Group , Principal Financial Group Inc , Get Free Report , General Counsel David , American Investors , Asset Management , Capital Growth , Principal Financial Group , Financial Group , Apellis Pharmaceuticals Daily ,

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) General Counsel David O. Watson Sells 4,184 Shares

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) General Counsel David O. Watson Sells 4,184 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Davido Watson , Robertw Baird , Apellis Pharmaceuticals Inc , Advisor Group Holdings Inc , Needham Company , Apellis Pharmaceuticals , Apellis Pharmaceuticals Stock Down , Neuberger Berman Group , First Horizon Advisors Inc , Apellis Pharmaceuticals Company Profile , News Ratings For Apellis Pharmaceuticals Daily , Quarter For Apellis Pharmaceuticals , Cim Investment Management Inc , Get Free Report , General Counsel David , Pharmaceuticals Stock Down , Investment Management , Group Holdings , North Carolina , Horizon Advisors , Berman Group , Apellis Pharmaceuticals Daily ,

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Down Following Insider Selling

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) gapped down before the market opened on Tuesday following insider selling activity. The stock had previously closed at $65.45, but opened at $63.81. Apellis Pharmaceuticals shares last traded at $63.90, with a volume of 195,943 shares changing hands. Specifically, CAO James George Chopas sold 864 […] ....

James George Chopas , Raymond James , Davido Watson , Institutional Trading Of Apellis Pharmaceuticals , National Bank , Stephens Consulting , Apellis Pharmaceuticals , News Ratings For Apellis Pharmaceuticals Daily , Jpmorgan Chase Co , Apellis Pharmaceuticals Inc , Covestor Ltd , Apellis Pharmaceuticals Stock , First Horizon Advisors Inc , Wealth Management Inc , Get Free Report , George Chopas , General Counsel David , Horizon Advisors , Apellis Pharmaceuticals Daily , Nasdaq Apls ,

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) General Counsel David O. Watson Sells 4,240 Shares

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) General Counsel David O. Watson sold 4,240 shares of the stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $66.81, for a total transaction of $283,274.40. Following the transaction, the general counsel now owns 109,261 shares in the company, […] ....

United States , Davido Watson , Stephens Consulting , Apellis Pharmaceuticals Stock Performance , Apellis Pharmaceuticals Company Profile , Quarter For Apellis Pharmaceuticals , Apellis Pharmaceuticals Inc , Jpmorgan Chase Co , Hedge Funds Weigh In On Apellis Pharmaceuticals , Wealth Management Inc , News Ratings For Apellis Pharmaceuticals Daily , First Horizon Advisors Inc , Covestor Ltd , National Bank , Goldman Sachs Group , Apellis Pharmaceuticals , Get Free Report , General Counsel David , Horizon Advisors , Apellis Pharmaceuticals Daily , Nasdaq Apls , Insider Trading , Nsider Trades ,

Apellis Pharmaceuticals (NASDAQ:APLS) Trading Up 3.9%

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) were up 3.9% on Monday . The stock traded as high as $46.37 and last traded at $46.18. Approximately 1,177,061 shares were traded during mid-day trading, a decline of 57% from the average daily volume of 2,755,496 shares. The stock had previously closed at $44.44. […] ....

Raymond James , Alec Machiels , Davido Watson , Pricet Rowe Associates Inc , Institutional Investors Weigh In On Apellis Pharmaceuticals , Apellis Pharmaceuticals Inc , News Ratings For Apellis Pharmaceuticals Daily , Apellis Pharmaceuticals , Needham Company , Wells Fargo Company , Insider Activity At Apellis Pharmaceuticals , Jpmorgan Chase Co , Norges Bank , Apellis Pharmaceuticals Stock Performance , Vanguard Group Inc , Get Free Report , Wells Fargo , Director Alec Machiels , General Counsel David , State Street Corp , Street Corp , Apellis Pharmaceuticals Daily , Nasdaq Apls ,